Orchestra BioMed Holdings (OBIO) Other Working Capital Changes (2022 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Other Working Capital Changes came in at -$172000.0 in Q1 2026, up 76.5% year-on-year from -$97448.9 in Q1 2025, and down 19.44% on a QoQ basis from -$144000.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 5 years of Other Working Capital Changes data on file, last reported at -$172000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 76.5% year-over-year to -$172000.0 in Q1 2026; TTM through Mar 2026 was $10000.0, a 101.13% increase from a year earlier, with the FY2025 full-year figure at -$550000.0, up 15.64% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$172000.0, down from -$144000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for OBIO reached as high as $1.5 million in Q1 2023 and fell as low as -$774000.0 in Q2 2023.
- Historically, Other Working Capital Changes has averaged $111058.8 across 5 years, with a median of -$35000.0 in 2025.
- Across the five-year window, Other Working Capital Changes sank 1192.68% in 2023 and soared 180.25% in 2024, its largest moves.
- Year by year, Other Working Capital Changes stood at -$123000.0 in 2022, then sank by 1192.68% to -$1.6 million in 2023, then surged by 180.25% to $1.3 million in 2024, then slumped by 111.29% to -$144000.0 in 2025, then slipped by 19.44% to -$172000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$172000.0 in Q1 2026, -$144000.0 in Q4 2025, and $993000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 477,000.00 |
| Mar 31, 2026 | 477,000.00 |
| Mar 31, 2026 | 477,000.00 |
| Dec 31, 2025 | -593,000.00 |
| Dec 31, 2025 | -593,000.00 |
| Dec 31, 2025 | -593,000.00 |
| Sep 30, 2025 | -139,000.00 |
| Sep 30, 2025 | -139,000.00 |
| Sep 30, 2025 | -139,000.00 |
| Jun 30, 2025 | -113,000.00 |
| Jun 30, 2025 | -113,000.00 |
| Jun 30, 2025 | -113,000.00 |
| Mar 31, 2025 | -35,000.00 |
| Mar 31, 2025 | -35,000.00 |
| Mar 31, 2025 | -35,000.00 |
| Dec 31, 2024 | 534,000.00 |
| Dec 31, 2024 | 534,000.00 |
| Dec 31, 2024 | 534,000.00 |
| Sep 30, 2024 | 590,000.00 |
| Sep 30, 2024 | 590,000.00 |